Fennec Pharmaceuticals (FENC) Other financing activities (2020 - 2024)

Fennec Pharmaceuticals (FENC) has 4 years of Other financing activities data on file, last reported at $1.7 million in Q1 2024.

• For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2024 stood at $1.7 million (changed N/A YoY), and the FY2024 full-year result was $1.7 million, up 57900.0% from the prior year.
• Other financing activities for Q1 2024 stood at $1.7 million, up from $63000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $1.7 million in Q1 2024 and bottomed at $23000.0 in Q2 2020.
• The 4-year median for Other financing activities is $52500.0 (2021), against an average of $335333.3.
• The widest annual swing landed in 2021, when Other financing activities jumped 82.61%; it then soared 133.33% in 2022.
• A 4-year view of Other financing activities shows it stood at $117000.0 in 2020, then sank by 76.92% to $27000.0 in 2021, then jumped by 133.33% to $63000.0 in 2022, then jumped by 2661.9% to $1.7 million in 2024.
• The last three Other financing activities figures came in at $1.7 million (Q1 2024), $63000.0 (Q4 2022), and $27000.0 (Q4 2021), per Business Quant data.

Peer Comparison